Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 61 citing articles:

Why does COVID-19 disproportionately affect older people?
Amber L. Mueller, Maeve S. McNamara, David Sinclair
Aging (2020) Vol. 12, Iss. 10, pp. 9959-9981
Open Access | Times Cited: 983
Epigenetic mechanisms regulating COVID-19 infection
Sarantis Chlamydas, Athanasios G. Papavassiliou, Christina Piperi
Epigenetics (2020) Vol. 16, Iss. 3, pp. 263-270
Open Access | Times Cited: 123
Sex Disparities in COVID-19 Severity and Outcome: Are Men Weaker or Women Stronger?
Rosario Pivonello, Renata S. Auriemma, Claudia Pivonello, et al.
Neuroendocrinology (2020) Vol. 111, Iss. 11, pp. 1066-1085
Open Access | Times Cited: 123
Biomarkers of COVID-19 and technologies to combat SARS-CoV-2
Luoping Zhang, Helen Guo
Advances in Biomarker Sciences and Technology (2020) Vol. 2, pp. 1-23
Open Access | Times Cited: 112
Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19
Jilei Zhang, Shari Garrett, Jun Sun
Genes & Diseases (2020) Vol. 8, Iss. 4, pp. 385-400
Open Access | Times Cited: 87
COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
Naveen L. Pereira, Ferhaan Ahmad, Mirnela Byku, et al.
Mayo Clinic Proceedings (2020) Vol. 96, Iss. 2, pp. 446-463
Open Access | Times Cited: 84
Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation
Steven Andrew Baker, Shirley Kwok, Gerald J. Berry, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0247060-e0247060
Open Access | Times Cited: 84
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective
Sarah Halawa, Soni Savai Pullamsetti, Charles R. M. Bangham, et al.
Nature Reviews Cardiology (2021) Vol. 19, Iss. 5, pp. 314-331
Open Access | Times Cited: 74
Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus1
Tasnim H. Beacon, Geneviève P. Delcuve, James Davie
Genome (2020) Vol. 64, Iss. 4, pp. 386-399
Open Access | Times Cited: 71
The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy
Fei Chen, Yankun Zhang, Xiaoyun Li, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 60
SARS-CoV-2 and cancer: Are they really partners in crime?
Peter A. van Dam, Manon Huizing, Gino Mestach, et al.
Cancer Treatment Reviews (2020) Vol. 89, pp. 102068-102068
Open Access | Times Cited: 68
Methylation Pathways and SARS-CoV-2 Lung Infiltration and Cell Membrane-Virus Fusion Are Both Subject to Epigenetics
Leo Pruimboom
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 66
Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review
Ettore Crimi, Giuditta Benincasa, Neisaliz Figueroa-Marrero, et al.
British Journal of Anaesthesia (2020) Vol. 125, Iss. 6, pp. 1002-1017
Open Access | Times Cited: 52
The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19
Mahda Delshad, Naeimeh Tavakolinia, Atieh Pourbagheri‐Sigaroodi, et al.
International Immunopharmacology (2021) Vol. 95, pp. 107586-107586
Open Access | Times Cited: 42
ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues
Sally Badawi, Bassam R. Ali
Human Genomics (2021) Vol. 15, Iss. 1
Open Access | Times Cited: 41
The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic
Maria Karoliny da Silva Torres, Carlos David Araújo Bichara, Maria de Nazaré do Socorro de Almeida, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 30
An Immune Epigenetic Insight to COVID-19 Infection
Bimal Prasad Jit, Sahar Qazi, Rakesh Arya, et al.
Epigenomics (2021) Vol. 13, Iss. 6, pp. 465-480
Open Access | Times Cited: 35
Epigenetic Lens to Visualize the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection in COVID-19 Pandemic
Nitin K. Saksena, Srinivasa Reddy Bonam, Monica Miranda‐Saksena
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 33
Epigenetic mechanisms regulate sex-specific bias in disease manifestations
Sarantis Chlamydas, Mariam Markouli, Dimitrios Strepkos, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 8, pp. 1111-1123
Open Access | Times Cited: 25
COVID-19 tsunami: the first case of a spinal cord injury patient in Italy
Gabriele Righi, Giulio Del Popolo
Spinal Cord Series and Cases (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 39
A NEW ERA FOR THE THERAPEUTIC MANAGEMENT OF THE ONGOING COVID-19 PANDEMIC
Andreea Letiția Arsene
FARMACIA (2020) Vol. 68, Iss. 2, pp. 185-196
Open Access | Times Cited: 38
Environmental Epigenetics and Genome Flexibility: Focus on 5-Hydroxymethylcytosine
Olga A. Efimova, Alla S. Koltsova, Mikhail I. Krapivin, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3223-3223
Open Access | Times Cited: 37
SARS‐CoV‐2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics
Tasnim H. Beacon, Ruey‐Chyi Su, Ted M. Lakowski, et al.
IUBMB Life (2020) Vol. 72, Iss. 11, pp. 2331-2354
Open Access | Times Cited: 34
The impact of gender on emotional reactions, perceived susceptibility and perceived knowledge about COVID-19 among the Israeli public
Inbar Levkovich, Shiri Shinan‐Altman
International Health (2020) Vol. 13, Iss. 6, pp. 555-561
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top